AR043823A1 - Compuestos derivados de oxima, su preparacion y elaboracion de medicamentos que los contienen - Google Patents
Compuestos derivados de oxima, su preparacion y elaboracion de medicamentos que los contienenInfo
- Publication number
- AR043823A1 AR043823A1 ARP040101103A ARP040101103A AR043823A1 AR 043823 A1 AR043823 A1 AR 043823A1 AR P040101103 A ARP040101103 A AR P040101103A AR P040101103 A ARP040101103 A AR P040101103A AR 043823 A1 AR043823 A1 AR 043823A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- preparation
- compounds derived
- oxima
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Compuestos derivados de oxima, sus sales farmacéuticamente aceptables así como sus formas enantioméricas, sus diastereoisómeros y sus racematos; la obtención de los compuestos recién mencionados, los medicamentos que los contienen y su fabricación así como el uso de los compuestos recién mencionados como inhibidores de desacetilasa de histona (HDAC), para la inhibición del crecimiento tumoral o el tratamiento del cáncer, o para la fabricación de los medicamentos correspondientes. Reivindicación 1: Un compuesto de la fórmula (1) en la que R1 es H o alquilo C1-4; R2 es arilo, heteroarilo o heterociclilo; todos ellos pueden estar opcionalmente sustituidos una o varias veces con alquilo; halógeno; -O-alquilo; -NH(alquilo); -N(alquilo)2; o R1 y R2 junto con el átomo de C al que están unidos forman un hidrocarburo cíclico; y sales farmacéuticamente aceptables del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03007829 | 2003-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043823A1 true AR043823A1 (es) | 2005-08-17 |
Family
ID=33104054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040101103A AR043823A1 (es) | 2003-04-04 | 2004-04-01 | Compuestos derivados de oxima, su preparacion y elaboracion de medicamentos que los contienen |
Country Status (14)
Country | Link |
---|---|
US (1) | US7173060B2 (es) |
EP (1) | EP1613622A1 (es) |
JP (1) | JP2006515345A (es) |
KR (1) | KR100733757B1 (es) |
CN (1) | CN1771247A (es) |
AR (1) | AR043823A1 (es) |
AU (1) | AU2004226215A1 (es) |
BR (1) | BRPI0409182A (es) |
CA (1) | CA2519301A1 (es) |
CL (1) | CL2004000732A1 (es) |
MX (1) | MXPA05010424A (es) |
RU (1) | RU2005133994A (es) |
TW (1) | TW200424187A (es) |
WO (1) | WO2004087693A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4725944B2 (ja) | 2002-03-13 | 2011-07-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒストンデアセチラーゼの阻害剤 |
NZ534831A (en) | 2002-03-13 | 2007-01-26 | Janssen Pharmaceutica Nv | Carbonylamino-derivatives having histone deacetylase (HDAC) inhibiting enzymatic activity |
DE60321667D1 (en) | 2002-03-13 | 2008-07-31 | Janssen Pharmaceutica Nv | Piperazinyl-, piperidinyl- und morpholinylderivate als neue inhibitoren von histon-deacetylase |
NZ534771A (en) | 2002-03-13 | 2006-04-28 | Janssen Pharmaceutica Nv | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
MX2007001120A (es) | 2004-07-28 | 2007-03-15 | Janssen Pharmaceutica Nv | Derivados de indolil alquil sustituidos como nuevos inhibidores de la histona desacetilasa. |
NZ599464A (en) | 2005-02-03 | 2014-03-28 | Topotarget Uk Ltd | Combination therapies using hdac inhibitors |
US8835501B2 (en) | 2005-05-13 | 2014-09-16 | Topotarget Uk Limited | Pharmaceutical formulations of HDAC inhibitors |
US8138198B2 (en) | 2005-05-18 | 2012-03-20 | Angibaud Patrick Rene | Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase |
EP1904452A2 (en) | 2005-07-14 | 2008-04-02 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
AU2006313517B2 (en) | 2005-11-10 | 2013-06-27 | Topotarget Uk Limited | Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent |
AU2007206950B2 (en) | 2006-01-19 | 2012-02-02 | Janssen Pharmaceutica N.V. | Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
DK1979328T3 (da) | 2006-01-19 | 2013-03-25 | Janssen Pharmaceutica Nv | Pyridin- og pyrimidinderivater i deres egenskab af histondeacetylasehæmmere |
EP1979326B1 (en) | 2006-01-19 | 2012-10-03 | Janssen Pharmaceutica N.V. | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
CN101374828B (zh) | 2006-01-19 | 2012-09-19 | 詹森药业有限公司 | 作为组蛋白脱乙酰酶抑制剂的杂环烷基衍生物 |
JP5137848B2 (ja) | 2006-01-19 | 2013-02-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体 |
JP5225104B2 (ja) | 2006-01-19 | 2013-07-03 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 新しい、ヒストンデアセチラーゼのインヒビターとしてのアミノフェニル誘導体 |
CA2680838A1 (en) | 2007-03-28 | 2008-10-16 | Santen Pharmaceutical Co., Ltd. | Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient |
CN101868446A (zh) | 2007-09-25 | 2010-10-20 | 托波塔吉特英国有限公司 | 某些异羟肟酸化合物的合成方法 |
EP2268611A2 (en) * | 2008-04-02 | 2011-01-05 | Amira Pharmaceuticals, Inc. | Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
SI2307007T1 (sl) * | 2008-07-23 | 2014-11-28 | Novartis Ag | Modulatorji sfingozin 1 fosfatnega receptorja in njihova uporaba za zdravljenje mišičnega vnetja |
US9265734B2 (en) | 2008-09-03 | 2016-02-23 | Biomarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors |
US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
CA2828524C (en) | 2011-02-28 | 2020-01-07 | Repligen Corporation | Histone deacetylase inhibitors |
NZ711585A (en) | 2013-03-15 | 2020-05-29 | Biomarin Pharm Inc | Hdac inhibitors |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1033046B (it) | 1970-10-31 | 1979-07-10 | Finotto Martino | Procedimento di fabbricazione di benzimidazoli sostituiti |
DE2201062A1 (de) | 1972-01-11 | 1973-07-26 | Bayer Ag | N-alkoxycarbonyl- bzw. n-alkylthiocarbonyl-2-(2'-thienyl)-benzimidazole, ein verfahren zu ihrer herstellung und ihre verwendung als fungizide |
NZ219974A (en) | 1986-04-22 | 1989-08-29 | Goedecke Ag | N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases |
JPH0692398B2 (ja) * | 1987-07-07 | 1994-11-16 | 日本農薬株式会社 | ピラゾ−ルオキシム誘導体及び該化合物を含有する殺菌殺虫殺ダニ剤 |
US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
US20020103192A1 (en) | 2000-10-26 | 2002-08-01 | Curtin Michael L. | Inhibitors of histone deacetylase |
US6784173B2 (en) | 2001-06-15 | 2004-08-31 | Hoffmann-La Roche Inc. | Aromatic dicarboxylic acid derivatives |
JP4641670B2 (ja) * | 2001-06-28 | 2011-03-02 | 株式会社フジタ | 水浄化構造 |
AR034897A1 (es) * | 2001-08-07 | 2004-03-24 | Hoffmann La Roche | Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos |
-
2004
- 2004-03-30 TW TW093108684A patent/TW200424187A/zh unknown
- 2004-03-31 US US10/814,410 patent/US7173060B2/en not_active Expired - Fee Related
- 2004-04-01 AR ARP040101103A patent/AR043823A1/es not_active Application Discontinuation
- 2004-04-02 MX MXPA05010424A patent/MXPA05010424A/es active IP Right Grant
- 2004-04-02 BR BRPI0409182-5A patent/BRPI0409182A/pt not_active IP Right Cessation
- 2004-04-02 KR KR1020057018818A patent/KR100733757B1/ko not_active IP Right Cessation
- 2004-04-02 CL CL200400732A patent/CL2004000732A1/es unknown
- 2004-04-02 WO PCT/EP2004/003498 patent/WO2004087693A1/en active Application Filing
- 2004-04-02 CN CNA2004800092703A patent/CN1771247A/zh active Pending
- 2004-04-02 EP EP04725309A patent/EP1613622A1/en not_active Withdrawn
- 2004-04-02 RU RU2005133994/04A patent/RU2005133994A/ru not_active Application Discontinuation
- 2004-04-02 JP JP2006500084A patent/JP2006515345A/ja active Pending
- 2004-04-02 AU AU2004226215A patent/AU2004226215A1/en not_active Abandoned
- 2004-04-02 CA CA002519301A patent/CA2519301A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1613622A1 (en) | 2006-01-11 |
CL2004000732A1 (es) | 2005-02-04 |
RU2005133994A (ru) | 2006-06-27 |
KR20060011947A (ko) | 2006-02-06 |
TW200424187A (en) | 2004-11-16 |
AU2004226215A1 (en) | 2004-10-14 |
CA2519301A1 (en) | 2004-10-14 |
MXPA05010424A (es) | 2005-11-04 |
BRPI0409182A (pt) | 2006-04-11 |
JP2006515345A (ja) | 2006-05-25 |
KR100733757B1 (ko) | 2007-06-29 |
CN1771247A (zh) | 2006-05-10 |
WO2004087693A1 (en) | 2004-10-14 |
US7173060B2 (en) | 2007-02-06 |
US20040214880A1 (en) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR043823A1 (es) | Compuestos derivados de oxima, su preparacion y elaboracion de medicamentos que los contienen | |
ES2525763T3 (es) | Derivados del ácido fenilalcanoico sustituido y sus usos para el tratamiento de enfermedades respiratorias | |
CO2021003298A2 (es) | Compuestos de sulfonamidaurea novedosos | |
CY1122933T1 (el) | Ενωσεις θειαζολοκαρβοξαμιδιων και πυριδινοκαρβοξαμιδιου χρησιμες ως αναστολεις κινασης ριμ | |
ECSP20044709A (es) | Inhibidores de sarcómero cardíaco | |
AR065876A1 (es) | Compuestos activos para 11 beta -hsd1 | |
AR087668A1 (es) | Derivados de oxazina y su uso en el tratamiento de enfermedades | |
UY35377A (es) | Compuestos de 1,3-oxazin-2-amina fusionados con ciclopropilo perfluorado como inhibidores de beta-secretasa y métodos de uso | |
CO6140033A2 (es) | Amino-imidazoles y su uso como medicamento para tratar discapacidad coognotiva enfermedad de alzheimer neurodegeneracion y demencia | |
EA201490445A1 (ru) | Циклопропанаминовое соединение | |
AR085960A1 (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
AR077478A2 (es) | Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos | |
UY31940A (es) | Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones | |
EA201070523A1 (ru) | Производные фталазинона | |
AR068055A1 (es) | Derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol su procedimiento de preparacion su aplicacion como medicamentos composiciones farmaceuticas y su utilizacion principalmente como inhibidores de met | |
EA201000805A1 (ru) | Бис-(сульфониламино)производные в терапии 066 | |
AR087915A1 (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1 | |
AR057162A1 (es) | Compuestos de benzamida como inhibidores de la enzima histona desacetilasa (hdac) | |
UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
JP2013509392A5 (es) | ||
BR112019021853A2 (pt) | Compostos de inibidor de vmat2 e composições dos mesmos | |
AR066972A1 (es) | Derivados azapeptidicos | |
NI202000058A (es) | Moduladores de sting (estimulador de genes de interferón) a base de ciclopentano | |
PE20040913A1 (es) | Enantiomeros (r) y (s) de derivados del acido tiofeno hidroxamico como inhibidores de desacetilasa histona (hdac) | |
CY1109376T1 (el) | Παραγωγα υδαντοϊνης χρησιμα ως αναστολεις μεταλλοπρωτεϊνασης |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |